Scan that makes prostate cancer cells glow could cut need for biopsies
Reports and Proceedings
Updates every hour. Last Updated: 3-Jun-2026 05:16 ET (3-Jun-2026 09:16 GMT/UTC)
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found.
Australia: Dementia, global trends, community attitudes, conscientious objections by doctors and health facilities, Indigenous perspectives, and organ donation are among agenda topics for the International Conference on Assisted Dying and Other End of Life Care (ICEL5) at QUT next month.
Falls are one of the leading causes of injury and hospitalization among older adults, placing significant strain on individuals, families and the health-care system.
And new research by UBC Okanagan’s Dr. Jennifer Davis shows that money spent to prevent additional falls and avoid significant injuries among older adults at high risk of future falls yields a strong return on the dollar.
As the use of injectable GLP-1 drugs continues to rise, questions persist about what happens after patients stop taking them in real-world settings.
A new Cleveland Clinic analysis of nearly 8,000 patients suggests that discontinuing semaglutide and tirzepatide, on average, does not lead to significant weight regain in clinical practice, as many patients later restart the original medication or try an alternative obesity treatment.
In one of the largest real-world studies to date examining obesity treatment use and long-term weight changes after GLP-1 discontinuation, researchers at Cleveland Clinic found that many patients successfully stabilized their weight after one year through alternative treatments and therapeutic lifestyle interventions.
The findings published in the journal Diabetes, Obesity and Metabolism.A team of researchers at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC has identified important differences in how early Alzheimer’s disease-related brain changes appear across racial and ethnic groups, underscoring the need for more inclusive approaches to studying and diagnosing the disease. In a large, racially and ethnically diverse study of older adults without dementia, researchers found that Black and Hispanic participants showed higher levels of tau, a protein linked to Alzheimer’s, in key memory-related regions of the brain compared to non-Hispanic white participants, even before the buildup of amyloid plaques typically associated with Alzheimer’s disease. The findings come from the Health and Aging Brain Study–Health Disparities (HABS-HD), one of the largest and most diverse brain-imaging studies of aging in the US and were made possible by advanced PET brain scans that can detect abnormal protein buildup years before symptoms appear. Using a newer generation tau PET tracer, the research team examined brain scans and memory test results from more than 1,500 adults who were cognitively normal or had mild cognitive impairment. While higher tau levels were linked to worse memory overall, amyloid buildup strengthened this link only in non-Hispanic white and Hispanic participants, not in Black participants. This suggests that memory changes in Black adults may be influenced more strongly by factors beyond amyloid and tau alone. Vascular health, the presence of other health conditions, life-long stress exposure, and other social factors may play a prominent role and deserve closer study.
A new technique transforms any computer vision model into one that can explain its predictions using a set of concepts a human could understand. The method generates more appropriate concepts that boost the accuracy of the model